On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
On Nov. 14, 2025, A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma’s latest deal…
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
On Oct. 29, 2025, the U.S. Food and Drug Administration (FDA) announced it is aiming to reduce the…
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
On Oct. 8, 2025, The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in…
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
On Oct. 3, 2025, the U.S. Food and Drug Administration (FDA) announced a new pilot prioritization program for…
On Sept. 30, 2025, Pfizer announced an agreement with the Trump Administration that will ensure U.S. patients pay…
On Sept. 25, 2025, Glaukos, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
On Sept. 16, 2025, Eli Lilly announced that it plans to build a $5 billion manufacturing facility just…
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
On Sept. 9, 2025, Eli Lilly announced the launch of Lilly TuneLab, an artificial intelligence and machine learning…
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…